Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Vivo Bio Tech Ltd Performance

Today's Low
42.00
arrowIcon
Today's High
43.20
52 Wk Low
21.05
arrowIcon
52 Wk High
56.00


Open

43.2

Traded Value (Cr)

1.49 L

Prev. Close

41.46

VWAP

41.83

Volume

3,499

Face Value

10

Vivo Bio Tech Ltd Fundamentals

Market Cap
₹ 65 Cr
P/E Ratio (TTM)
16.85
P/B Ratio
1.24
Debt to Equity
1.15
ROE
5.12 %
EPS (TTM)
2.59
Dividend Yield
0.00%
Book Value
35.12

Click here to know more about Fundamentals

Vivo Bio Tech Ltd Financials

Vivo Bio Tech Ltd Financials

Vivo Bio Tech Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 42.08 % 42.08 % 42.08 % 42.08 %
Others 32.57 % 34.40 % 34.49 % 34.06 %
Retail 25.35 % 23.52 % 23.43 % 23.86 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

42.08%

Others

32.57%

Retail

25.35%

FII

0.00%

Mutual Funds

0.00%

Promoters

42.08%

Others

34.40%

Retail

23.52%

FII

0.00%

Mutual Funds

0.00%

Promoters

42.08%

Others

34.49%

Retail

23.43%

FII

0.00%

Mutual Funds

0.00%

Promoters

42.08%

Others

34.06%

Retail

23.86%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹43.60

PIVOT

resistance-arrow
Resistance
First Resistance₹45.193
Second Resistance₹46.897
Third Resistance₹48.493
support-arrow
Support
First Resistance₹41.893
Second Resistance₹40.297
Third Resistance₹38.593
RSI30.135
MACD-0.842
ADX21.779
CCI-263.759

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day40,66525,82863.51
Week19,89112,97065.02
1 Month29,46521,48972.47
6 Months000.00

About Vivo Bio Tech Ltd

Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients, we distinguish your development plan is as superlative as the products you bring to our testing facilities. The Biologic Research Services group at Vivo Bio Tech offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged & poorly expressed proteins. In-vitro Services offers solutions for pharmacologic, toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays, chromosomal aberration, and micronucleus are specialty services by our scientists. The In-vivo Services group at Vivo Bio Tech provides both non-regulatory and regulatory IND enabling preclinical development services. We are capable of screening & evaluating molecules for various pharmacological & therapeutic properties. Specifically for oncology, our scientists can provide design & development of xenograft models for evaluation of anti-cancer agents. Further, our scientists can customize in-vivo DMPK studies to help profile your drug candidate in both rodent and non-rodent animal models. Vivo Bio has partnered with Taconic for sourcing foundation and expansion colonies of the animal models and have started in-house breeding of Specific Pathogen Free rodents.

Managing Director

Founded

1987

NSE Symbol

Vivo Bio Tech Ltd Management

NameDesignation
Kalyan Ram MangipudiWhole-time Director
Alangudi SankaranarayananWhole-time Director
K SunderChairman & Independent Directo
Hariharan RavindranIndependent Director
Kunda KalpanaIndependent Director
Karopadi Shivanand NayakDirector
K Sri KalyanWhole Time Director & CFO
Shyam Sunder TipparajuAdditional Director

Vivo Bio Tech Ltd News

Vivo Bio Tech schedules board meeting
On 20 May 2024
Vivo Bio Tech consolidated net profit rises 780.00% in the December 2023 quarter
Sales decline 5.10% to Rs 12.85 crore
Vivo Bio Tech to convene board meeting
On 12 February 2024
Vivo Bio Tech announces board meeting date
On 14 November 2023
Vivo Bio Tech to convene board meeting
On 21 September 2023
Vivo Bio Tech to conduct AGM
On 30 September 2023
Vivo Bio Tech consolidated net profit declines 56.25% in the June 2023 quarter
Sales rise 2.84% to Rs 11.58 crore
Vivo Bio Tech to declare Quarterly Result
On 7 August 2023
Vivo Bio Tech to table results
On 30 May 2023
Vivo Bio Tech consolidated net profit declines 89.05% in the December 2022 quarter
Sales rise 4.80% to Rs 13.54 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,58,304 Cr
₹ 1,513.45
(1.35 %)
86.97
CIPLA₹ 1,09,708 Cr
₹ 1,365.20
(0.47 %)
33.36
DIVISLAB₹ 1,00,599 Cr
₹ 3,817.80
(0.75 %)
73.75
DRREDDY₹ 98,073 Cr
₹ 5,888.60
(0.16 %)
22.59
ZYDUSLIFE₹ 97,383 Cr
₹ 984.90
(1.77 %)
36.23

Vivo Bio Tech Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Vivo Bio Tech Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Vivo Bio Tech Ltd's share price is ₹42.52 as of May 10, 2024

Vivo Bio Tech Ltd's P/E ratio is 16.85 times as of May 10, 2024.

Vivo Bio Tech Ltd's most recent financial reports indicate a price-to-book ratio of 1.24, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Vivo Bio Tech Ltd's market is 65 Cr as on May 10, 2024.

The current financial records of Vivo Bio Tech Ltd show a 5.12% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Vivo Bio Tech Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Vivo Bio Tech Ltd's 52-week high and low as of May 10, 2024 are ₹43.2 and ₹42 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Vivo Bio Tech Ltd stands at 42.08%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.